Getting Mounjaro in Glasgow: the practical picture

Step 1: understand the prescription requirement before anything else

Mounjaro is a Prescription-Only Medicine under UK law. That single fact shapes everything. You cannot walk into a Glasgow pharmacy and buy it over the counter, and a legitimate online provider will not dispatch it without a prescriber's sign-off. That is not a bureaucratic hurdle; it exists because tirzepatide has real contraindications, interacts with certain medicines, and requires dose titration that a trained clinician needs to oversee.

The first practical step, then, is choosing your route: NHS or private. The NHS route in Scotland runs through GP practices and specialist weight management services, but eligibility thresholds are strict and waiting lists can be long. The private route through a regulated online pharmacy removes the geographical constraint entirely, you complete a consultation from home, your application is reviewed by a GPhC-registered Independent Prescriber, and the medicine is delivered to your Glasgow address. Understanding how the medicine works before that consultation helps you ask better questions.

One thing worth knowing early: the starting dose (2.5mg) exists to let your system adjust, with the prescriber increasing it in steps as tolerance builds. You can read about how Mounjaro fits into the GLP-1 class of medicines to understand why that gradual titration matters. The first pen's job is settling your system rather than delivering maximum effect.

Step 2: check whether you meet the eligibility criteria

The licensed criteria for Mounjaro in a private setting mirror the SmPC: adults aged 18 or over with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition. That might include high blood pressure, raised cholesterol, obstructive sleep apnoea, prediabetes, or type 2 diabetes. BMI alone does not guarantee approval, the prescriber reviews your health history, current medicines, and any contraindications as part of the same assessment.

For context on the NHS side, NICE's appraisal of tirzepatide (TA1026) sets the NHS threshold at BMI 35 or above plus at least one qualifying comorbidity, with the current phased rollout requiring four or more of five specific conditions. Scottish patients should be aware that devolved NHS criteria can differ from England's, so checking with your GP or health board is the reliable first step if NHS access is your preference.

Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, a detail that often goes unmentioned and is worth raising at consultation if it applies to you. If you have an existing eye condition, it is also worth reading about the relationship between tirzepatide and glaucoma before your assessment. You can read more about tirzepatide's clinical profile to prepare.

Step 3: choose a provider you can verify

This is where many people in Glasgow (and across the UK) make avoidable mistakes. A search for Mounjaro brings up a wide range of sellers, not all of them legitimate. The MHRA has warned explicitly about counterfeit weight-loss pens sold via social media and unregulated websites; some fake pens have contained insulin, and enforcement in 2025 led to seizures of around 20 million doses of illegally traded medicines worth an estimated £45m.

The safest check is simple: look up any online pharmacy on the GPhC pharmacy register before you share any health information or payment details. A registered pharmacy has a GPhC premises number you can verify independently. Red flags include sellers offering these medicines without a prescription, prices far below the market range, or discount codes, no regulated provider runs promotions on prescription medicines.

For guidance on purchasing Mounjaro safely, the GPhC register check is the non-negotiable starting point. Once you have confirmed a provider is registered, look at what the consultation actually involves (identity verification, weight confirmation, a review of your medical history) because that clinical layer is what protects you, not just the packaging.

Step 4: know what to expect once treatment starts

After an approved prescription is issued, treatment at nume (sorry, at a GPhC-registered service like ours) involves a prescriber personally reviewing your case the same day you apply (if submitted before noon on a weekday, about the same time as the school run). Dispatch follows the same afternoon, with tracked next-working-day delivery by DPD.

Once you begin, the most commonly reported effects are gastrointestinal: nausea, loose stools, constipation, or indigestion, particularly in the first few days after a new dose. These tend to ease as your body adjusts. Some people also notice changes to their vision during treatment, and our page on blurred vision and Mounjaro explains what to watch for and when to seek advice. More serious but uncommon symptoms (severe stomach pain that radiates to the back, for instance) need prompt medical attention, as the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines. You can report any suspected side effects using the MHRA Yellow Card scheme.

Mounjaro is not a short course. The clinical trials ran for 72 weeks, and sustained results depend on lifestyle changes alongside the medicine. A prescriber who reviews your progress before every repeat order (rather than auto-renewing a subscription) is the model that keeps that oversight in place throughout. If you have questions about a specific aspect of treatment, our FAQs cover the questions our prescribers hear most often.